2016
DOI: 10.1136/gutjnl-2016-312049
|View full text |Cite
|
Sign up to set email alerts
|

Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis

Abstract: UMIN000001818; Results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
105
1
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(110 citation statements)
references
References 33 publications
(50 reference statements)
1
105
1
3
Order By: Relevance
“…However, a recent randomized controlled study showed significantly higher relapse rates in the "stopprednisolone-group" (57.9%) as compared to the "maintenance-therapy-group" (23%) in which no steroid-associated side effects were found [46], clearly supporting maintenance therapy (Fig. 2).…”
Section: Steroidsmentioning
confidence: 85%
“…However, a recent randomized controlled study showed significantly higher relapse rates in the "stopprednisolone-group" (57.9%) as compared to the "maintenance-therapy-group" (23%) in which no steroid-associated side effects were found [46], clearly supporting maintenance therapy (Fig. 2).…”
Section: Steroidsmentioning
confidence: 85%
“…From a serological point of view, pathogenesis of AIP can be attributed to autoimmunity, as indicated by specific serologic abnormalities and the dramatic response to steroid therapy[20]. AIP patients show high incidences of hypergammaglobulinemia (43%), increased levels of IgG (62–80%), IgG4 (68–92%) and antinuclear antibodies (40–64%), rheumatoid factor (25%) [14, 21, 22].…”
Section: Discussionmentioning
confidence: 99%
“…We read with great interest the article by Masamune et al 1 regarding the role of long-term maintenance corticosteroids in patients with autoimmune pancreatitis (AIP) 1. AIP is a steroid responsive disorder, which has two distinct entities with overlapping features, classified as type I and type II AIP.…”
mentioning
confidence: 99%